Alidaee MR (2005)
Alidaee MR, Taheri A, Mansoori P et al. Silver nitrate cautery in aphthous stomatitis: a randomized controlled trial. British Journal of Dermatology 2005; 153: 521-525.
Alves MB (2004)
Alves MB, Motta AC, Messina WC et al. Saliva substitute in xerostomic patients with primary Sjögren’s syndrome: a single-blind trial. Quintessence International 2004; 35: 392-396.
Avritscher EB (2004)
Avritscher EB, Cooksley CD, Elting LS. Scope and epidemiology of cancer therapy-induced oral and gastrointestinal mucositis. Seminars in Oncology Nursing 2004; 20: 3-10.
Barasch A (2006)
Barasch A, Elad S, Altman A et al. Antimicrobials, mucosal coating agents, anesthetics, analgesics, and nutritional supplements for alimentary tract mucositis. Supportive Care in Cancer 2006; 14: 528-532.
Barber C (2007)
Barber C, Powell R, Ellis A et al. Comparing pain control and ability to eat and drink with standard therapy vs Gelclair: a preliminary, double centre, randomised controlled trial on patients with radiotherapy-induced oral mucositis. Supportive Care in Cancer 2007; 15: 427-40.
Björnström M (1990)
Björnström M, Axéll T, Birkhed D. Comparison between saliva stimulants and saliva substitutes in patients with symptoms related to dry mouth. A multi-centre study. Swedish Dental Journal 1990; 14: 153-161.
Borowski B (1994)
Borowski B, Benhamou E, Pico JL et al. Prevention of oral mucositis in patients treated with high-dose chemotherapy and bone marrow transplantation: a randomized controlled trial comparing two protocols of dental care. European Journal of Cancer, Part B Oral Oncology.1994; 30B: 93-97.
Broek van den AM (2008)
Broek van den AM, Feenstra L, Baat de C. A review of the current literature on management of halitosis. Oral Diseases 2008; 14: 30-39.
Brown CG (2004)
Brown CG, Wingard J. Clinical consequences of oral mucositis. Seminars in Oncology Nursing 2004; 20: 16-21.
Buchsel PC (2008)
Buchsel PC. Polyvinylpyrrolidone-sodium hyaluronate gel (Gelclair): a bioadherent oral gel for the treatment of oral mucositis and other painful oral lesions. Expert Opin Drug Metab Toxicol 2008; 4: 1449-1454.

Burgess JA (1990)
Burgess JA, Johnson BD, Sommers E. Pharmacological management of recurrent oral mucosal ulceration. Drugs 1990; 39: 54-65.
Carvalho MD (2004)
Carvalho MD, Tabchoury CM, Cury JA et al. Impact of mouthrinses on morning bad breath in healthy subjects. Journal of Clinical Periodontology 2004; 21: 85-90.
Cerchietti LC (2002)
Cerchietti LC, Navigante AH, Bonomi MR et al. Effect of topical morphine for mucositis-associated pain following concomitant chemoradiotherapy for head and neck carcinoma. Cancer 2002; 95: 2230-2236.
Cerchietti LC (2003)
Cerchietti LC, Navigante AH, Körte MW et al. Potential utility of the peripheral analgesic properties of morphine in stomatitis-related pain: a pilot study. Pain 2003; 105: 265-273.
Cha R (2004)
Cha R, Sobel JD. Fluconazole for the treatment of candidiasis: 15 year experience. Expert Review of Anti-infective Therapy 2004; 2: 357-366.
Clarkson JE (2007)
Clarkson JE, Worthington HV, Eden OB. Interventions for preventing oral candidiasis for patients with cancer receiving treatment. Cochrane Database of Systematic Reviews 2007 ; 1: CD003807.

Clarkson JE (2007)
Clarkson JE, Worthington HV, Eden OB. Interventions for treating oral mucositis for patients with cancer receiving treatment. Cochrane Database of Systematic Reviews 2007; 2: CD001973.

Davies A (2002)
Davies A, Brailsford S, Broadley K et al. Resistance amongst yeasts isolated from the oral cavities of patients with advanced cancer. Palliative Medicine 2002; 16: 527-531.

Davies A (2005)
Davies A. Oral care in advanced disease. Davies A, Finlay IG , eds. Oxford, New York:Oxford University Press 2005: 1-6.

Davies AN (2001)
Davies AN, Broadley K, Beighton D. Xerostomia in patients with advanced cancer. Journal of Pain and Symptom Management 2001; 22: 820-825.
Davies AN (1998)
Davies AN, Daniels C, Pugh R et al. A comparison of artificial saliva and pilocarpine in the management of xerostomia in patients with advanced cancer. Palliative Medicine 1998; 12: 105-111.
Davies AN (2007)
Davies AN, Shorthose K. Parasympathomimetic drugs for the treatment of salivary gland dysfunction due to radiotherapy. Cochrane Database of Systematic Reviews 2007; 3: CD0033782.
Davies AN (2000)
Davies AN. A comparison of artificial saliva and chewing gum in the management of xerostomia in patients with advanced cancer. Palliatieve Medicine 2000; 14: 197-203.
Davies AN (1997)
Davies AN. The management of xerostomia: a review. European Journal of Cancer Care 1997; 6: 209-214.
Dodd MJ (1996)
Dodd MJ, Larson PJ, Dibble SL et al. Randomized clinical trial of chlorhexidine versus placebo for prevention of oral mucositis in patients receiving chemotherapy. Oncology Nursing Forum 1996; 23: 921-927.
Ehrnrooth E (2001)
Ehrnrooth E, Grau C, Zachariae R et al. Randomized trial of opioids versus tricyclic antidepressants for radiation-induced mucositis pain in head and neck cancer. Acta Oncologica 2001; 40: 745-750.
Eilers J (2004)
Eilers J, Epstein JB. Assessment and measurement of oral mucositis. Seminars in Oncology Nursing 2004; 20: 22-29.
Epstein JB (2010)
Epstein JB, Barasch A. Taste disorders in cancer patients: pathogenesis, and approach to assessment and management. Oral Oncology 2010; 46: 77-81.
Epstein JB (2007)
Epstein JB, Elad S, Eliav E et al. Orofacial pain in cancer: part II – clinical perspectives and management. Journal of Dental Research 2007; 86: 506-18.
Epstein JB (1999)
Epstein JB, Emerton S, Le ND et al. A double-blind crossover of Oral Balance gel and Biotene toothpaste versus placebo in patients with xerostomia following radiation therapy. Oral Oncology 1999; 35: 132-137.
Freer SK (2000)
Freer SK. Use of an oral assessment tool to improve practice. Professional Nurse 2000; 15: 635-637.
Futran ND (1997)
Futran ND, Trotti A, Gwede C. Pentoxifylline in the treatment of radiation-related soft tissue injury: preliminary observations. Laryngoscope 1997; 107: 391-395.
Gillam JL (2006)
Gillam JL, Gillam DG. The assessment and implementation of mouth care in palliative care: a review. Journal of the Royal Society of Promotion Health 2006; 126: 33-37.
Goodschild JH (2009)
Goodschild JH, Donaldson M. Appropriate antibiotic prescribing for the general dentist. General Dentistry 2009; 57: 626-634.
Guchelaar HJ (1997)
Guchelaar HJ, Vermes A, Meerwalt JH. Radiation-induced xerostomia: pathophysiology, clinical course and supportive treatment. Supportive Care in Cancer 1997; 5; 281-288.
Halyard `MY (2007)
Halyard `MY, Jatoi A, Sloan JA et al. Does zinc sulfate prevent therapy-induced taste alterations in head and neck cancer patients? Results of phase III double-blind, placebo-controlled trial from the North Central Cancer Treatment Group (NO1C4). International Journal of Radiotherapy Oncology, Biology, Physics 2007: 67: 1318-1322.
Harris DJ (2008)
Harris DJ, Eilers J, Harriman A et al. Putting evidence into practice: evidence-based interventions for the management of oral mucositis. Clinical Journal of Oncology Nursing 2008; 12: 141-152.
Harris DJ (2004)
Harris DJ, Knobf MT. Assessing and managing chemotherapy-induced mucositis pain. Clinical Journal of Oncology Nursing 2004; 8: 622-628.
Hawthorne M (2000)
Hawthorne M, Sullivan K. Pilocarpine for radiation-induced xerostomia in head and neck cancer. International Journal of Palliative Nursing 2000; 6: 228-232.
Henkin RI (1976)
Henkin RI, Schecter PJ, Friedewald WT et al. A double blind study on the effects of zinc sulfate on taste and smell dysfunction. American Journal of Medical Science 1976; 272: 285-299.
Henkin RI (1972)
Henkin RI. Prevention and treatment of hypogeusia due to head and neck irradiation. JAMA 1972; 220: 870-871.
Holmes S (1998)
Holmes S. Xerostomia: aetiology and management in cancer patients. Supportive Care in Cancer 1998; 6: 348-355.
Hong JH (2009)
Hong JH, Omur-Ozbek P, Stanek BT et al. Taste and odor abnormalities in cancer patients. Journal of Supportive Oncology 2009; 7: 58-65.
Hovan AJ (2010)
Hovan AJ, Williams PM, Stevenson-Moore P et al. A systematic review of dysgeusia induced by cancer therapies. Support Care Cancer 2010; (Epub ahead of print).
Jobbins J (1992)
Jobbins J, Addy M, Bagg J et al. A clinical trial of chlorhexidine oral spray in terminally ill cancer patients. Palliative Medicine 1992; 6: 299-307.
Keefe DM (2007)
Keefe DM, Schubert MM, Elting LS et al. Updated clinical practice guidelines for the prevention and treatment of mucositis. Cancer 2007; 109: 820-831.
Kozlak ST (2010)
Kozlak ST, Walsh SJ, Lalla RV. Reduced dietary intake of vitamin B12 and folate in patients with recurrent aphthous stomatitis. Journal of Oral Pathology and Medicine 2010; Feb 7 (Epub ahead of print).
Kwong KK (2004)
Kwong KK. Prevention and treatment of oropharyngal mucositis following cancer therapy. Cancer Nursing 2004; 27: 183-205.
Laverty D (2007)
Laverty D. Treating cancer-related breakthrough pain: the oral transmucosal route. International Journal of Palliative Nursing 2007; 13: 326-331.
Lopez-Jornet P (2010)
Lopez-Jornet P, Camacho-Alfonso F, Martinez-Canovas A. Clinical evaluation of polyvinylpyrrolidone sodium hyaluronate gel and 0.2% chlorhexidine gel for pain after oral mucosa biopsy: a preliminary study. J Oral Maxillofac Surg 2010; 68: 2159-2163.
Lotfi-Jam K (2008)
Lotfi-Jam K, Carey M, Jefford M et al. Nonpharmacologic strategies for managing common chemotherapy adverse effects: a systematic review. Journal of Clinical Oncology 2008; 26: 5618-5629.
Louis J (1997)
Louis J, Moyer J, Angelini J et al. Metronidazole oral rinse helps to alleviate odor associated with oral lesions. Oncology Nursing Forum 1997; 24: 1331.
McCarthy GM (1998)
McCarthy GM, Awde JD, Ghandi Het al. Risk factors associated with mucositis in cancer patients receiving 5-fluorouracil. Oral Oncology 1998; 34: 484-490.
McGuire DB (2006)
McGuire DB, Correa ME, Johnson J et al. The role of basic oral care and good clinical practice principles in the management of oral mucositis. Supportive Care in Cancer 2006; 14: 541-547.
Meredith R (1997)
Meredith R, Salter M, Kim R et al. Sucralfate for radiation mucositis: results of a double-blind randomized trial. International Journal of Radiation Oncology Biology Physics 1997; 37: 275-279.
Migliorati CA (2005)
Migliorati CA, Schubert MM, Peterson DE et al. Bisphosphonate-associated osteonecrosis of the mandibular and maxillary bone: an emerging oral complication of supportive cancer therapy. Cancer 2005; 104: 83-93.
Miller M (2001)
Miller M, Kearney N. Oral care for patients with cancer: a review of the literature. Cancer Nursing 2001; 24: 241-254.
Milligan S (2001)
Milligan S, McGill M, Sweeney MP et al. Oral care for people with advanced cancer: an evidence-based protocol. International Journal of Palliative Nursing 2001; 7: 418-426.
Nieuw Amerongen AV (2003)
Nieuw Amerongen AV, Veerman EC. Current therapies for xerostomia and salivary gland hypofunction associated with cancer therapies. Supportive Care in Cancer 2003; 11: 226-231.
Nolan A (2009)
Nolan A. Interventions for prevention and treatment of herpes simplex virus in cancer patients. Evidence Based Dentistry 2009; 10: 116-117.
Oneschuk D (2000)
Oneschuk D, Hanson J, Bruera E. A survey of mouth pain and dryness in patients with advanced cancer. Supportive Care in Cancer 2000; 8: 372-376.
Papas AS (2003)
Papas AS, Clark RE, Martuscelli G et al. A prospective, randomized trial for the prevention of mucositis in patients undergoing hematopoietic stem cell transplantation. Bone Marrow Transplant. 2003; 31: 705-12.
Pillitteri LC (1998)
Pillitteri LC, Clarke RE. Comparison of a patient-controlled analgesia system with continuous infusion for administration of diamorphine for mucositis. Bone Marrow Transplantation 1998; 22: 495-498.
Potting CM (2004)
Potting CM, Achterberg van T. Het meten van orale mucositis. Verpleegkunde 2004; 19: 300-313.
Potting CM (2008)
Potting CM, Mank A, Blijlevens NM et al. Providing oral care in haematological oncology patients: nurses' knowledge and skills. European Journal of Oncology Nursing. 2008; 12: 291-298.
Potting CM (2006)
Potting CM, Uitterhoeve R, Op Reimer WS et al. The effectiveness of commonly used mouthwashes for the prevention of chemotherapy-induced oral mucositis: a systematic review. European Journal of Cancer Care 2006; 15: 431-439.
Raber-Durlacher JE (2004)
Raber-Durlacher JE, Barasch A, Peterson DE et al. Oral complications and management considerations in patients treated with high-dose chemotherapy. Supportive Cancer Therapy 2004; 1: 219-229.
Raber-Durlacher JE (2002)
Raber-Durlacher JE, Epstein JB, Raber J et al. Periodontal infection in cancer patients treated with high-dose chemotherapy. Supportive Care in Cancer 2002; 10: 466-473.
Regelink G (1998)
Regelink G, Vissink A, Reintsema H et al. Efficacy of a synthetic polymer saliva substitute in reducing oral complaints of patients suffering from irradiation-induced xerostomia. Quintessence International 1998; 29: 383-386.
Ripamonti C (1998)
Ripamonti C, Zecca E, Brunelli C et al. A randomized, controlled clinical trial to evaluate the effect of zinc sulfate on cancer patients with taste alterations caused by head and neck irradiation. Cancer 1998; 82: 1938-1945.
Roldán S (2005)
Roldán S, Herrera D, O’Connor A et al. A combined therapeutic approach to manage oral halitosis: a 3 months prospective case series. Journal of Periodontology 2005; 76; 1025-1033.
Samaranayake L (2010)
Samaranayake L, Sitheeque M. Oral fungal infections. In: Davies AN, Epstein JB eds. Oral complications of cancer and its management. Oxford, New York: Oxford University Press Oxford 2010; pp 171-183.
Sbanotto A (2002)
Sbanotto A. Oral complications of cancer. In: Ripamonti C, Bruera E. Gastrointestinal symptoms in advanced cancer patients. Oxford: Oxford University Press, 2002, pp. 81-113.
Scannapieco F (2003)
Scannapieco F, Bush RB, Paju S. Associations between periodontal disease and risk for nosocomial bacterial pneumonia and chronic obstructive pulmonary disease. A systematic review. Annals of Periodontology 2003; 8: 54-69.
Schubert MM (1991)
Schubert MM. Oral manifestations of viral infections in immunocompromised patients. Current Opinion in Dentistry 1991; 1: 384-397.
Scully C (1994)
Scully C, Porter S, Greenman J. What to do about halitosis. British Medical Journal 1994; 308: 217-218.
Scully C (2008)
Scully C, Porter S. Oral mucosal disease: recurrent aphthous stomatitis. British Journal of Oral and Maxillofacial Surgery 2008; 46: 198-206.
Shiboski CH (2007)
Shiboski CH, Hodgson T, Ship JA et al. Management of salivary hypofunction during and after radiotherapy. Oral Surgery, Oral Medicne, Oral Pathology, Oral Radiology and Endodontics 2007; 103: S66.e1-S66.e19.
Shieh SH (1997)
Shieh SH, Wang ST, Tsai ST et al. Mouth care for nasopharyngeal cancer patients undergoing radiotherapy. Oral Oncology 1997; 33: 36-41.
Söder B (2000)
Söder B, Johansson B, Söder PO. The relation between foetor ex ore, oral hygiene and periodontal disease. Swedish Dental Journal 2000; 24: 73-82.
Sonis ST (2004)
Sonis ST, Elting LS, Keefe D et al. Perspectives on cancer therapy-induced mucosal injury: pathogenesis, measurement, epidemiology, and consequences for patients. Cancer 2004; 100(9 Suppl): 1995-2025.
Sreebny LM (1988)
Sreebny LM, Valdini A. Xerostomia. Part I: Relationship to other oral symptoms and salivary gland hypofunction. Oral Surgery, Oral Medicine and Oral Pathology 1988; 66: 451-458.
Stokman MA (2008)
Stokman MA, Vissink A, Spijkervet FK. Focusonderzoek en mondverzorging bij patiënten met kanker. Nederlands Tijdschrift voor Tandheelkunde 2008; 115: 203-210.
Stone P (1999)
Stone P, A’Hern R. Artificial saliva versus pilocarpine for xerostomia. Palliative Medicine 1999; 13: 81-83.
Stone R (2007)
Stone R, Potting CM, Clare S et al. Management of oral mucositis at European transplantation centres. European Journal of Oncology Nursing 2007; 11 (Suppl 1): S3-S9.
Strupp C (2000)
Strupp C, Sudhoff T, Germing U et al. Transdermal fentanyl during high-dose chemotherapy and autologous stem cell support. Oncology Reports 2000; 7: 659-661.
SWAB (2008)
SWAB. Richtlijn Invasieve Schimmelinfecties, 2008:
Swart EL (2001)
Swart EL, Waal van der I, Wilhelm AJ. Orale bijwerkingen van geneesmiddelen. Geneesmiddelenbulletin 2001; 35: 133-137.
Sweeney MP (1997)
Sweeney MP, Bagg J, Baxter WP et al. Clinical trial of a mucin-containing oral spray for treatment of xerostomia in hospice patients. Palliative Medicine 1997; 11: 225-232.
Trotti A (2003)
Trotti A, Bellm LA, Epstein JB et al. Mucositis incidence, severity and associated outcomes in patients with head and neck cancer receiving radiotherapy with or without chemotherapy: a systematic literature review. Radiotherapy and Oncology 2003; 66: 253-262.
Uitterhoeve RJ (2000)
Uitterhoeve RJ. Richtlijn verhoogd risico op beschadigd mondslijmvlies; Richtlijn beschadigd mondslijmvlies. Landelijke Oncologische Verpleegkundige Richtlijnen, patroon 2.4, 2000.
Velthuizen L (1993)
Velthuizen L, Lugt-Lustig de K, Nieweg R. Vijf protocollen voor mondverzorging. TvZ/vakblad voor verpleegkundigen 1993: 21: 720-724.
Vissink A (1983)
Vissink A, ‘s-Gravenmade EJ, Panders AK et al. A clinical comparison between commercially available mucin- and CMC-containing saliva substitutes. International Journal of Oral Surgery 1983; 12: 232-238.
Vissink A (2003)
Vissink A, Burlage FR, Spijkervet FK et al. Prevention and treatment of the consequences of head and neck radiotherapy. Critical Review of Oral and Biological Medicine 2003; 14: 213-225.
Vissink A (2001)
Vissink A, Spijkervet FK, Stegenga B. Geneesmiddelen bij aandoeningen van mond, gebit en kaak. Geneesmiddelenbulletin 2001; 35: 119-126.
Winkel EG (2003)
Winkel EG, Roldán S, Winkelhoff van AJ et al. Clinical effects of a new mouthrinse containing chlorhexidine, cetylpyridinium chloride and zinc-lactate on oral halitosis. A dual-center, double-blind placebo-controlled study. Journal of Clinical Periodontology 2003; 30: 300-306.
Worthington HV (2007)
Worthington HV, Clarkson JE, Eden OB. Interventions for preventing oral mucositis for patients with cancer receiving treatment. Cochrane Database of Systematic Reviews 2007; 4: CD000978.